• ICYMI: OPA's Pre-budget Consultation Submission
• FIP Guidance Resources for Managing Coronavirus in Pharmacy
• New Awards to Celebrate Leslie Dan Faculty of Pharmacy Alumni
• University of Waterloo Survey on Readiness to Assess and Prescribe for Minor Ailments
• ICYMI: Elimination of Red and White Health Cards
• 2nd Coalition of Pharmacists Caring for Aging Canadians (CPCAC) Scientific Meeting

• *Free* Methadone, Buprenorphine and the Community
• Rational Prescribing: Re-Thinking Medications
• *Free* Assessment and Management of Patients with Migraine

• Ask the Customer Experience Administration Team

• Planning to Retire or Moving to Part B?

• DDD Notice No. 20027 posted February 10, 2020 Trillium Drug Program - New Online Application Form and Guide
• DDD Notice No. 20028 posted February 11, 2020 Prescription Forgery Alert

• Drug Shortage / Supply Health System Alert: Dexamethasone, Ranitidine, Tamoxifen February 7, 2020

• Apotex Inc. Recalls Certain Lots of Diabetes Medication APO-Metformin ER (extended release) 500 mg Tablets

• Novel Coronavirus (2019-nCoV) Resources
• Deadline to Apply to Allied Health Professional Development Fund is March 2, 2020

• Opioid Addictions and Substitution Therapy FREE Live Webinar Series
• Essential Cannabis Knowledge for Pharmacists Certificate Program
• Applying NAPRA’s Non-Sterile Compounding Standards into Practice

• Ask the Practice Support Network

• Store Owners, Did You Know?

• DDD Notice No. 20015 Posted February 3, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification
• DDD Notice No. 20016 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20017 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20018 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20019 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20020 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20021 posted February 4, 2020 Prescription Forgery Alert
• DDD Notice No. 20022 posted February 4, 2020 Prescription Forgery Alert

• Drug Shortage / Supply Health System Alert: Effient (Prasugrel)

• Health Product InfoWatch - January 2020

• Ministry of Health Emergency Operations Centre Provides More Resources for Novel Coronavirus (2019-nCoV)
• Pillar of Pharmacy Award Nominations

• Certified Diabetes Educator (CDE) Preparation Course
• Essential Cannabis Knowledge for Pharmacists Certificate Program
• Methadone, Buprenorphine and the Community

• Ask the Customer Experience Administration Team

• Shopping for Auto Insurance?
• Last Chance to Avoid an Interruption in Your Professional Liability Insurance

• ODB Formulary – Edition No. 43, Summary of Changes – January 2020

• Last Chance to Have Your Say on Pre-budget Consultations - Complete Our Survey
• University of Toronto: Class of 2023 White Coat Ceremony
• Fluwatch - Register to Monitor Flu Activity
• Clinical Guidelines on Substance Use Disorders in Older Adults from the Canadian Coalition for Seniors' Mental Health
• Resources from the Ontario Caregiver Organization

• Methadone, Buprenorphine and the Community
• Pharmacist Health Coaching – Cardiovascular Program Training Course
• FAQs and a New Drugs Update on Contraception and Abortion Care

• Ask the Practice Support Network
• Looking for Things to Do With the Kids?

• OPA Pharmacy (Store) Insurance

• DDD Notice No. 20009 Posted January 16, 2020 Prescription Forgery Alert
• DDD Notice No. 20010 Posted January 20, 2020 Health Network System (HNS) and Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
• DDD Notice No. 20011 Posted January 21, 2020 Prescription Forgery Alert
• DDD Notice No. 20012 Posted January 21, 2020 Prescription Forgery Alert

• Pharmascience Inc. recalls one lot of prescription antifungal drug PMS-Nystatin Oral Suspension: Product may pose a choking risk

• ICYMI: OPA Surveys on Compounding and Pre-Budget Consultations
• University of Waterloo: Class of 2023 White Coat Ceremony
• University of Toronto - Last Call for Applications for OPA's Summer Student Position
• Health Quality Ontario Surgical Site Injections Quality Standard Advisory Committee

• Methadone, Buprenorphine and the Community
• Managing Your Pharmacy: The Business Essentials
• Applying NAPRA’s Non-Sterile Compounding Standards into Practice

• Ask the Customer Experience and Administration Team
• Reminder: Drug Information and Resource Centre (DIRC) Closure

• Are You Financially Protected from a Serious Illness?

• DDD Notice No. 20006 posted January 10, 2020 Elimination of Red and White Health Cards
• DDD Notice No. 20007 posted January 13, 2020 Health Network System (HNS) And Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies

• Drug Shortage / Supply Health System Alert: Raltitrexed 2mg/vial

• Tools and Resources to Assist Members with NAPRA Model Standards for Pharmacy Compounding of Non-Sterile Preparations
• Class Action Authorized For People In Canada Who Used ABILIFY® And Experienced Impulse Control Disorders
• Attention U of T Students - Work for OPA and Help Shape the Future of Pharmacy

• Delivering a Comprehensive Pharmacy-Based Vaccines Program
• Collaborating with Family Physicians: The Rx for Success
• An Update on Direct Oral Anticoagulation

• Ask the Practice Support Network
• OPA's 2020 Early Bird Membership Draw Winners

• Professional Liability Insurance: Mind Your Policy Language

• DDD Notice No. 20003 posted January 6, 2020 Health Network System (HNS) and Narcotics Monitoring System Outage Notification to Ontario Drug Programs Agencies

• Happy New Year from OPA!
• HURRY! OPA Membership Expires TODAY

• REMINDER: Mandatory Cannabis Education Training Due March 2020
• Applying NAPRA’s Non-Sterile Compounding Standards into Practice
• Selling What You Can Do for Your Clients Program
• Medical Devices Training for Pharmacy Technicians

• Ask the Customer Experience and Administration Team

• OPA Secure Health Plan: All-in-one healthcare package

• Happy holidays from OPA!
• Have your say on common (minor) ailments
• Congratulations pharmacy graduates!

• Professional Development Clinical Bundle
• Professional Development Operational Bundle
• Professional Development Pharmacy Technician Bundle

• Ask the Practice Support Network
• Dell’s Biggest Boxing Week Ever
• OPA Membership Deadline is December 31, 2019

• What is Critical Illness insurance?

• Drug Shortage / Supply Health System Alert: Sterile Mineral Oil 100% - 30 ml vial
• Drug Shortage / Supply Health System Alert: Etoposide and Raltitrexed
• Drug Shortage / Supply Health System Alert: Raltitrexed 2mg/vial
• Drug Shortage / Supply Health System Alert: Etoposide

• DDD Notice No. 19194 Posted December 23, 2019 Executive Officer Notice: Updates to the Ontario Guidelines for Drug Submission and Evaluation
• DDD Notice No. 19193 posted December 23, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and Dispensing Fee Act to reduce Administrative Burden to Drug • • • Manufacturers and Pharmacies
• DDD Notice No. 19192 posted December 19, 2019 Drug Submission Notice: New Submission Deadline Time for Multiple Source Products
• DDD Notice No. 19191 posted December 16, 2019 Notice: Policy for Pharmacy Payments under the Long-Term Care Home Capitation Funding Model, 2020 - UPDATE

Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream - Advisory
U-Dream herbal sleep-aid products - Advisory
Important Safety Information on GILENYA (fingolimod) and the Risk of Congenital Malformations - Novartis Pharmaceuticals Canada Inc.
Health Product InfoWatch - Safety Updates: Polyethylene glycol 3350